MX2009005445A - Sistema de suministro para risperidona. - Google Patents

Sistema de suministro para risperidona.

Info

Publication number
MX2009005445A
MX2009005445A MX2009005445A MX2009005445A MX2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A
Authority
MX
Mexico
Prior art keywords
risperidone
delivery system
polymer
formulation
skin
Prior art date
Application number
MX2009005445A
Other languages
English (en)
Spanish (es)
Inventor
Wouter De Graaff
Armin Szegedi
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of MX2009005445A publication Critical patent/MX2009005445A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2009005445A 2006-11-22 2007-11-21 Sistema de suministro para risperidona. MX2009005445A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124598 2006-11-22
PCT/EP2007/062628 WO2008062009A1 (en) 2006-11-22 2007-11-21 Delivery system for risperidone

Publications (1)

Publication Number Publication Date
MX2009005445A true MX2009005445A (es) 2009-06-02

Family

ID=37898528

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009005445A MX2009005445A (es) 2006-11-22 2007-11-21 Sistema de suministro para risperidona.
MX2009005444A MX2009005444A (es) 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009005444A MX2009005444A (es) 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.

Country Status (6)

Country Link
US (2) US20100104619A1 (enExample)
EP (2) EP2094270A1 (enExample)
JP (2) JP2010510286A (enExample)
CA (2) CA2670157A1 (enExample)
MX (2) MX2009005445A (enExample)
WO (2) WO2008062008A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) * 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
CA2437639C (en) * 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
US7858110B2 (en) 2003-08-11 2010-12-28 Endo Pharmaceuticals Solutions, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
EP2037938A2 (en) * 2006-07-12 2009-03-25 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
EP2094270A1 (en) * 2006-11-22 2009-09-02 N.V. Organon Delivery system for risperidone
WO2009129459A1 (en) * 2008-04-18 2009-10-22 Combinent Biomedical Systems, Inc. Devices that include ethylene-vinyl acetate copolymers and methods of making and using same
RU2510266C2 (ru) * 2008-09-30 2014-03-27 Эндо Фармасьютикалз Солюшнз Инк. Имплантируемое устройство для доставки рисперидона и способы его применения
WO2010105093A2 (en) * 2009-03-12 2010-09-16 Delpor, Inc. Implantable device for long-term delivery of drugs
LT2547332T (lt) 2010-03-16 2018-12-10 Titan Pharmaceuticals, Inc. Heterogeninės implantuojamos priemonės, skirtos vaisto pristatymui
US20170319833A1 (en) * 2010-03-28 2017-11-09 Evestra, Inc. Intravaginal drug delivery device
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10406336B2 (en) * 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
CA3087238A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
SG11202005949UA (en) 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US4469671A (en) * 1983-02-22 1984-09-04 Eli Lilly And Company Contraceptive device
GB9326255D0 (en) * 1993-12-23 1994-02-23 Roussel Lab Ltd Medical device for the prevention and treatment of cancer
ES2166894T3 (es) * 1995-07-04 2002-05-01 Akzo Nobel Nv Dispositivos anulares.
US20040044080A1 (en) * 1997-10-28 2004-03-04 Place Virgil A. Treatment of dyspareunia with topically administered nitroglycerin formulations
IL157771A0 (en) * 2001-03-27 2004-03-28 Galen Chemicals Ltd Intravaginal drug delivery devices for the administration of an antimicrobial agent
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
AU2003272237B2 (en) * 2002-08-30 2009-11-19 Alza Corporation Embossable and writable multilaminate backing construction
AU2005206143B2 (en) * 2004-01-12 2010-12-16 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
JP2007530500A (ja) * 2004-03-24 2007-11-01 ナームローゼ・フエンノートチヤツプ・オルガノン ポリエチレン酢酸ビニル共重合体に基づく薬物送達システム
PT1824460E (pt) * 2004-11-10 2015-01-14 Tolmar Therapeutics Inc Um sistema de administração polimérico estabilizado
WO2008062021A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
EP2094270A1 (en) * 2006-11-22 2009-09-02 N.V. Organon Delivery system for risperidone

Also Published As

Publication number Publication date
JP2010510287A (ja) 2010-04-02
WO2008062008A1 (en) 2008-05-29
CA2670157A1 (en) 2008-05-29
MX2009005444A (es) 2009-06-02
EP2094348A1 (en) 2009-09-02
US20100104619A1 (en) 2010-04-29
JP2010510286A (ja) 2010-04-02
CA2670454A1 (en) 2008-05-29
EP2094270A1 (en) 2009-09-02
US20100203104A1 (en) 2010-08-12
WO2008062009A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
MX2009005445A (es) Sistema de suministro para risperidona.
WO2010057082A3 (en) Diagnostic capsules, delivery/retrieval systems, kits and methods
WO2010030728A3 (en) Devices and systems for delivery of therapeutic agents to body lumens
WO2012091748A3 (en) Therapeutic agent reservoir delivery system
WO2008100576A3 (en) Sustained delivery formulations of rapamycin compounds
WO2008148478A8 (de) Gastroretentives system mit alginat-körper
CA2770353C (en) Insertion device systems and methods
MX2009005446A (es) Sistema de suministro vaginal para mirtazapina.
WO2008093851A1 (ja) 体腔用医療機器及びその製造方法
WO2011143500A3 (en) Self contained illuminated infusion cannula systems and devices
WO2008101486A3 (de) Beschichtetes expandierbares system
WO2013085901A3 (en) Systems and methods for delivery of a medical device
WO2010035273A3 (en) Novel gastroretentive delivery system
WO2008063341A3 (en) Dual action, inhaled formulations providing both an immediate and sustained release profile
WO2010088698A3 (en) Antimicrobial accessory for an implantable medical device
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
WO2006084164A3 (en) Gastric retention and controlled release delivery system
WO2010105995A3 (en) Zoo-technical drug delivery device
WO2010019597A3 (en) Cyclo olefin polymer and copolymer medical devices
WO2010062589A3 (en) Device for delivery of antimicrobial agent into trans-dermal catheter
WO2007126531A3 (en) Methods and devices for deployment into a lumen
WO2008078318A3 (en) Systems and devices for sustained delivery of therapeutic fluid
WO2010103365A3 (en) Sustained release composition of therapeutic agent
WO2009032737A3 (en) Systems and methods for delivering medication
WO2014179615A3 (en) Biodegradable copolymers, forming and using same

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal